Format

Send to

Choose Destination
Crit Rev Microbiol. 2006;32(3):139-53.

Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies.

Author information

1
Department of Microbiology, College of Medicine, Howard University, Washington, DC 20059, USA. stai@howard.edu

Abstract

Streptococcus pneumoniae is a causative agent for community acquired pneumonia, bacteremia, acute otitis media, and meningitis. Recent emergence of multi-drug resistant clinical isolates prompts the need of effective vaccine for the prevention of disease. The licensed polysaccharide-based pneumococcal vaccines only elicit protective antibodies against the infection of serotypes that are included in the vaccine. To broaden the protection, the use of pneumococcal proteins will be a feasible and preferable alternative. This communication provides a review on the biochemical properties of these protein candidates, their immunization results in animal studies, and perspectives on the development of protein-based pneumococcal vaccine.

PMID:
16893751
DOI:
10.1080/10408410600822942
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center